Nothing Special   »   [go: up one dir, main page]

EP3999070A4 - An effervescent tablet composition of sitagliptin - Google Patents

An effervescent tablet composition of sitagliptin Download PDF

Info

Publication number
EP3999070A4
EP3999070A4 EP20841192.6A EP20841192A EP3999070A4 EP 3999070 A4 EP3999070 A4 EP 3999070A4 EP 20841192 A EP20841192 A EP 20841192A EP 3999070 A4 EP3999070 A4 EP 3999070A4
Authority
EP
European Patent Office
Prior art keywords
sitagliptin
effervescent tablet
tablet composition
composition
effervescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20841192.6A
Other languages
German (de)
French (fr)
Other versions
EP3999070A1 (en
Inventor
Seval Ataman
Muge ULUSOY BOZYEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3999070A1 publication Critical patent/EP3999070A1/en
Publication of EP3999070A4 publication Critical patent/EP3999070A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
EP20841192.6A 2019-07-17 2020-07-10 An effervescent tablet composition of sitagliptin Pending EP3999070A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/10633A TR201910633A1 (en) 2019-07-17 2019-07-17 EFERVESAN TABLET COMPOSITION WITH CYTAGLIPTIN
PCT/TR2020/050615 WO2021010924A1 (en) 2019-07-17 2020-07-10 An effervescent tablet composition of sitagliptin

Publications (2)

Publication Number Publication Date
EP3999070A1 EP3999070A1 (en) 2022-05-25
EP3999070A4 true EP3999070A4 (en) 2023-08-16

Family

ID=74209853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20841192.6A Pending EP3999070A4 (en) 2019-07-17 2020-07-10 An effervescent tablet composition of sitagliptin

Country Status (3)

Country Link
EP (1) EP3999070A4 (en)
TR (1) TR201910633A1 (en)
WO (1) WO2021010924A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116406666A (en) * 2023-04-12 2023-07-11 国网福建省电力有限公司电力科学研究院 Plant resistance inducer effervescent tablet and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (en) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Crystalline salts of sitagliptin
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077819A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic Pharmaceutical formulations comprising nateglinide
WO2013115744A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (en) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Crystalline salts of sitagliptin
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021010924A1 *

Also Published As

Publication number Publication date
EP3999070A1 (en) 2022-05-25
WO2021010924A1 (en) 2021-01-21
TR201910633A1 (en) 2021-05-21

Similar Documents

Publication Publication Date Title
EP3914252A4 (en) Pharmaceutical compositions of nilotinib
EP3849983A4 (en) Triazolo-pyrimidine compounds and uses thereof
EP3582777A4 (en) Pharmaceutical composition of apixaban
EP4082010A4 (en) Combining of spatial audio parameters
EP3728260A4 (en) Exo-aza spiro inhibitors of menin-mll interaction
EP4125815A4 (en) Therapeutic compositions
EP3927729A4 (en) Therapeutic antibody formulation
EP3630113A4 (en) Pharmaceutical composition comprising pde9 inhibitor
EP3917910A4 (en) Therapeutic compounds and compositions
EP3873444A4 (en) Therapeutic compounds and compositions
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3810118A4 (en) Formulations of tegavivint and related compounds
EP3781135A4 (en) Solid oral pharmaceutical compositions comprising sitagliptin
EP3976001A4 (en) Tablet formulations of apremilast
EP4077256A4 (en) Preparation of halogenated alkoxyethane
EP3873446A4 (en) Therapeutic compounds and compositions
EP3784672A4 (en) Tablet formulations comprising metformin and sitagliptin
EP3755376A4 (en) Formulations containing mucin-affecting proteases
EP3999070A4 (en) An effervescent tablet composition of sitagliptin
EP4081651A4 (en) Composition comprising mir-335
EP3894418A4 (en) Preparation of triiodosilanes
EP4077257A4 (en) Preparation of halogenated alkoxyethane
EP3972598A4 (en) Novel uses of crenolanib
EP3801532A4 (en) Formulations of raltegravir
EP3740204A4 (en) Solid forms of fasoracetam

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230717

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/00 20060101ALI20230711BHEP

Ipc: A61K 9/20 20060101ALI20230711BHEP

Ipc: A61K 9/46 20060101ALI20230711BHEP

Ipc: A61K 31/4985 20060101AFI20230711BHEP